US · DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares
- Sector
- Financial Services · Shell Companies
- Headquarters
- Fort Lauderdale, FL 33301
- Website
- dmaacorp.com
Price · as of 2024-12-31
$10.57
Market cap 350.59M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | |||||
| 2024 | $10.00 |
AI valuation
Our deep-learning model estimates Drugs Made In America Acquisition Corp. Ordinary Shares's (DMAA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $10.57
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| DMAA | Drugs Made In America Acq… | $10.57 | 350.59M | — | — | — | — | -178935.28 | -351270.49 | — | — | — | -351270.49 | 0.00% | — | — | — | — | — | -2.71 | — | 6.27 | 1.70 | — | — | — | — | 0.00% | -0.37 | — | 0.00% | 0.00% | 0.00% | -178933.84 | -295549.35 | — | 64637.96 |
| ALF | Centurion Acquisition Cor… | $10.77 | 387.05M | — | — | — | — | 30.62 | 0.85 | — | -512.57 | — | 0.85 | 0.00% | — | — | — | — | — | 0.00 | — | 6.39 | 5.32 | 1.42 | — | — | — | -0.07% | -1.32 | — | 0.00% | 0.00% | 0.00% | -512.57 | -1448.55 | — | 10.36 |
| LOKV | Live Oak Acquisition Corp… | $10.33 | 296.1M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | — | — | — | 9.08 | — | 0.14 | 0.00 | 0.00 | — | — | — | — | 0.00 | — | — | 0.00% | — | — | — | — | — |
| MLAC | Mountain Lake Acquisition… | $10.49 | 325.11M | — | — | — | — | 30.18 | 1.04 | — | -191.22 | 1.69 | 1.04 | 0.00% | — | — | 3.56% | -0.56% | 3.49% | 0.00 | — | 1.91 | 1.55 | 0.35 | 178811.00% | — | 48224.00% | -0.37% | -3.19 | -0.40% | 0.00% | 0.00% | 0.00% | -191.22 | -268.07 | — | 116.05 |
| SIMA | SIM Acquisition Corp. I | $10.77 | 330.28M | — | — | — | — | 65.57 | 1.38 | — | 65.42 | — | 1.38 | 0.00% | — | — | — | — | — | 0.00 | — | 25.28 | 21.38 | -0.15 | — | — | — | -0.27% | -25.88 | — | 0.00% | 0.00% | 0.00% | -539.46 | -368.00 | — | 16.94 |
| TACH | Titan Acquisition Corp. | $10.28 | 354.66M | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | — | — | — | -0.33 | — | 0.04 | 0.04 | 0.00 | — | — | — | — | -129.37 | — | — | 0.00% | — | — | — | — | — |
About Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.
- CEO
- Lynn Stockwell
- Employees
- 2
- Beta
- 3.19
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $10.57) − 1 = — (DCF, example).